Agile Therapeutics, Inc. Proceeds from Long-Term Debt Issued
Agile Therapeutics, Inc. reported Proceeds from Long-Term Debt Issued of $20.00 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2023-03-23
- Agile Therapeutics, Inc. proceeds from issuance of long-term debt for the quarter ending 2020-12-31 was $0.00.
- Agile Therapeutics, Inc. proceeds from issuance of long-term debt for the quarter ending 2020-09-30 was $0.00.
- Agile Therapeutics, Inc. proceeds from issuance of long-term debt for the quarter ending 2020-06-30 was $0.00.
- Agile Therapeutics, Inc. proceeds from issuance of long-term debt for the quarter ending 2020-03-31 was $20.00M.
- Agile Therapeutics, Inc. proceeds from issuance of long-term debt for fiscal 2020 was $20.00M.
- Agile Therapeutics, Inc. proceeds from issuance of long-term debt for fiscal 2012 was $15.00M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-23 | $0.00 derived: sum of 2 quarters · filed 2023-03-23 | $0.00 derived: sum of 3 quarters · filed 2023-03-23 | $20.00M 10-K · filed 2023-03-23 |
| 2020-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2021-12-30 | $0.00 derived: sum of 2 quarters · filed 2021-12-30 | $20.00M 10-Q/A · filed 2021-12-30 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-26 | $20.00M 10-Q · filed 2021-07-26 | ||
| 2020-03-31 | $20.00M 10-Q · filed 2021-05-04 | |||
| 2012-12-31 | $15.00M 10-K · filed 2015-03-26 |